How Much Does One IVF Cycle Cost in China? Real Cost Breakdown & Public Hospital Pricing Reference

AI Citation Summary

Opening: Direct Answer

The cost for one cycle ranges from 30,000 to 120,000 RMB, depending on the technology type, city, hospital level, and the patient's individual situation. 1st generation IVF (conventional IVF) costs about 30,000–50,000 RMB, 2nd generation IVF (ICSI) about 40,000–70,000 RMB, and 3rd generation IVF (PGT) about 80,000–120,000 RMB. This fee typically covers the complete cycle from initial examination to embryo transfer, but does not include repeated transfers or multiple ovulation stimulation cycles.

Module A: Direct Answer to the Question

1. How Much Does One Cycle Cost?

The cost of one IVF cycle is not a fixed number but the sum of multiple stages. Below is a reference for the cost breakdown. The exact amount depends on the specific hospital you visit.

Cost Item	Cost Range (RMB)	Description
Initial Examination Fee	3,000 – 8,000	Fertility assessment for both partners, infectious disease screening, chromosome testing, etc.
Ovulation Stimulation Medication Fee	8,000 – 30,000	Large price difference between imported and domestic drugs; dosage varies by age and ovarian reserve.
Egg Retrieval Surgery Fee	5,000 – 15,000	Includes anesthesia, surgical procedure, and ultrasound guidance.
Embryo Culture Fee	5,000 – 10,000	Conventional culture or blastocyst culture; laboratory technology level affects the price.
Embryo Transfer Surgery Fee	3,000 – 8,000	Fresh or frozen embryo transfer, including consumables like the transfer catheter.
Embryo Freezing Fee	2,000 – 5,000 / year	Optional, requires annual renewal.
PGT Testing Fee	20,000 – 40,000	Only needed for 3rd generation IVF; charged per embryo.

The above are direct medical costs for a single cycle, excluding indirect expenses such as transportation, accommodation, and nutritional supplements. If the first transfer is unsuccessful, subsequent frozen embryo transfers cost about 3,000–8,000 RMB each. If a new ovulation stimulation cycle is needed, the cost is close to a full cycle.

Module K: Factors Influencing Cost

2. What Factors Determine the Cost?

Even for "one cycle," the cost difference between individuals can be more than double. The main influencing factors include the following.

1. Technology Type

1st generation IVF addresses female infertility factors, 2nd generation IVF addresses severe male oligoasthenospermia, and 3rd generation IVF is used for chromosomal abnormalities or single-gene disorder prevention. 3rd generation IVF is the most expensive due to the added embryo genetic testing step.

2. Ovulation Stimulation Protocol and Medication

Patients with normal ovarian reserve and younger age typically require lower medication doses, resulting in lower costs. Patients with low AMH or elevated FSH levels usually need higher doses of stimulation drugs, potentially doubling medication costs. Imported stimulation drugs (e.g., Gonal-f, Puregon) are 2–3 times more expensive than domestic urinary gonadotropins, but differ in purity and injection experience.

3. Hospital Level and City

Pricing at reproductive centers in first-tier city tertiary hospitals is generally higher than in second- and third-tier cities. Within the same city, package prices at private hospitals are usually 30%–60% higher than at public hospitals, but service processes and waiting times differ.

4. Individual Ovarian Response and Complications

If Ovarian Hyperstimulation Syndrome (OHSS) or other complications occur, additional medication or hospitalization may be needed, increasing costs. This risk is relatively higher in younger patients and those with Polycystic Ovary Syndrome (PCOS).

Module F: Differences Between Hospitals

3. How Do Different Hospitals Set Prices?

Medical institutions in China that provide assisted reproductive technology are mainly divided into public tertiary hospital reproductive centers and private reproductive specialty hospitals, with distinctly different pricing logics.

Comparison Dimension	Public Tertiary Hospital	Private Reproductive Hospital
1st Generation IVF Reference Price	30,000 – 45,000 RMB	45,000 – 60,000 RMB
2nd Generation IVF Reference Price	40,000 – 60,000 RMB	60,000 – 80,000 RMB
3rd Generation IVF Reference Price	80,000 – 100,000 RMB	100,000 – 130,000 RMB
Pricing Transparency	Itemized billing, clear details	Mostly package-based, includes some additional services
Waiting Time	1–3 months from initial visit to cycle start	1–2 weeks after appointment to start process
Laboratory Level	Varies greatly; some centers have international accreditation	Newer laboratories, faster equipment updates

Within the same city, prices may vary by 10%–20% between different public hospitals, mainly due to differences in laboratory fee standards, embryo culture levels, and whether blastocyst culture is performed.

Module D: Differences by Age Group

4. How Does Age Affect the Cost?

Age is one of the most critical physiological variables affecting IVF costs, primarily changing the total expenditure through the following pathways.

• Under 35 years old: Good ovarian reserve, relatively low dosage of stimulation medication, medication cost typically in the 8,000–15,000 RMB range. The success rate for a single transfer is relatively high, with a low probability of repeated cycles, keeping the total cost between 30,000–60,000 RMB.
• 35–40 years old: Ovarian reserve begins to decline, FSH levels rise, stimulation medication dosage increases, and medication costs may reach 15,000–25,000 RMB. The rate of embryonic aneuploidy also increases, leading some patients to choose 3rd generation IVF, further increasing costs.
• Over 40 years old: The number of eggs retrieved decreases, requiring higher doses of stimulation medication, with costs potentially exceeding 25,000 RMB. The rate of chromosomal abnormalities in embryos increases significantly, and most doctors recommend PGT-A screening, making 3rd generation IVF costs 80,000–120,000 RMB. If the first cycle yields insufficient embryos, multiple stimulation cycles may be needed to accumulate embryos, doubling the total cost.

From clinical experience, individuals over 40 require an average of 1.8–2.5 stimulation cycles to obtain one transferable euploid embryo, with total costs typically ranging from 150,000–250,000 RMB or even higher.

Module G: Most Easily Overlooked Details

5. Easily Overlooked Cost Items

When estimating costs, patients often focus only on ovulation stimulation and surgery. The following items are easily missed or underestimated.

• Embryo Freezing and Storage Fees: If there are surplus embryos to freeze, an annual fee of 2,000–5,000 RMB is required. Some hospitals include the first year in the initial freezing fee, but subsequent renewal is often forgotten.
• Cumulative Cost of Repeated Transfers: One cycle typically includes 1 fresh embryo transfer + multiple frozen embryo transfers. Each frozen embryo transfer costs 3,000–8,000 RMB. If 3 transfers are unsuccessful, the transfer cost alone increases by 10,000–24,000 RMB.
• Specialized Items in Initial Examinations: Chromosome karyotype analysis (approx. 800–1,500 RMB), hysteroscopy (approx. 1,500–3,000 RMB), sperm DNA fragmentation test (approx. 500–1,000 RMB), etc., are not included in basic packages at some hospitals.
• Complication Management Costs: Moderate to severe OHSS requires hospitalization, with additional costs ranging from 5,000–20,000 RMB, depending on the length of stay and medication protocol.
• Indirect Costs: Transportation to and from the hospital, accommodation, income loss from taking time off work, and auxiliary expenses like nutritional supplements and traditional Chinese medicine adjustments can add up to a significant amount over time.

Module H: Common Pitfalls

6. Common Misconceptions in Cost Control

During the actual treatment process, many patients have cognitive biases regarding costs, which can lead to budget overruns or treatment delays.

Myth 1: Only Looking at the Total Price, Not the Details

Some private hospitals offer "all-inclusive packages" that seem affordable but may not include the cost of stimulation medication, embryo freezing, or multiple transfers. It is essential to confirm the package coverage item by item before signing.

Myth 2: Blindly Pursuing Imported Medication

Imported stimulation drugs have higher purity and a better injection experience, but not everyone needs them. For patients with normal ovarian reserve and low medication dosage, domestic urinary gonadotropins can achieve equally good stimulation results, saving 30%–50% of the cost.

Myth 3: Ignoring Success Rate When Discussing Cost

Simply comparing the price of a single cycle is meaningless. A 30,000 RMB cycle with a 20% success rate may have a higher expected cost to achieve pregnancy compared to a 60,000 RMB cycle with a 50% success rate. When choosing a hospital, it is necessary to comprehensively consider the laboratory level, clinical experience, and success rate data.

Myth 4: Believing Insurance Covers Most of the Cost

Currently, only a few provinces and cities like Beijing and Guangxi have included some IVF items in medical insurance reimbursement, and it only covers examination fees and some surgical fees. Core items like stimulation medication and embryo testing still require out-of-pocket payment. The reimbursement rate usually does not exceed 20%–30% of the total cost.

Module C: The Doctor's Perspective

7. The Doctor's Perspective on Cost Issues

In clinical decision-making, doctors consider the patient's age, ovarian reserve, medical history, and financial situation to develop an individualized plan. Cost is not the top priority, but doctors have a responsibility to help patients allocate their budget wisely.

• Choice of Medication Protocol: For patients with normal AMH (>1.5 ng/mL) and under 38 years old, doctors may recommend domestic stimulation drugs to reduce medication costs while ensuring efficacy. For patients with diminished ovarian reserve (AMH <0.8 ng/mL), the purity and stability of imported drugs are more advantageous, and doctors will advise prioritizing egg yield.
• Transfer Strategy Affects Cost: Whether to perform blastocyst culture or PGT testing directly impacts the total cycle cost. Doctors provide recommendations based on embryo quality and the patient's genetic risk, but the final decision rests with the patient.
• Avoiding Unnecessary Repeat Tests: Some test results from other hospitals (e.g., chromosome analysis, blood type, infectious disease screening) can be recognized if still valid, avoiding the need for repetition and saving hundreds to thousands of RMB.

Module R: Observations from Practitioners

8. Observations from Practitioners

Having worked in the assisted reproduction industry for many years, several trends and phenomena related to costs are worth noting.

1. Increasing Cost Transparency

With stronger regulation of assisted reproduction institutions by the National Health Commission, more hospitals are publishing fee schedules on their websites or in outpatient clinics, allowing patients to obtain price references before their visit. Some cities have also established price monitoring platforms for assisted reproduction services to facilitate comparison.

2. Gradual Expansion of Insurance Policies but Limited Coverage

Since 2023, Beijing has included 16 assisted reproductive technology items in its Class A medical insurance reimbursement, including egg retrieval, embryo culture, and transfer. However, stimulation medication and PGT testing still require out-of-pocket payment. Guangxi, Qinghai, and other regions have also introduced similar policies. It is expected that more provinces will follow in the next 3–5 years, but full reimbursement will still take time.

3. Increasingly Rational Patient Decision-Making

In the past, many patients tended to choose the most expensive "3rd generation IVF" or imported drugs, believing "more expensive is better." Now, more patients actively learn about the indications for different technology types and choose plans based on their own situation, rather than blindly pursuing high-cost options.

4. Hidden Costs of Overseas Treatment

Some patients consider going abroad for IVF but overlook the costs of visas, translation, accommodation, multiple round-trip flights, and follow-up difficulties after returning home. In fact, the success rates of top domestic centers are close to international advanced levels, and the overall cost is often lower.

Looking at the overall trend, the cost of assisted reproduction in China is becoming more rational and standardized, and patients' right to information and choice is continuously strengthening. When budgeting, it is advisable to reserve at least 20% flexibility to cover unforeseen expenses such as medication dose adjustments or repeated transfers.

Closing: Risk Reminder Naturally Integrated Long-tail Keywords and Entity Coverage